Latest Articles
Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer - HMP Global Learning Network
Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer HMP Global Learning Network
Published: May 26, 2026, 4:46 p.m.
Potential Immunotherapy After Immunotherapy in Select Endometrial Cancer Populations - CancerNetwork
Potential Immunotherapy After Immunotherapy in Select Endometrial Cancer Populations CancerNetwork
Published: May 25, 2026, 1:56 p.m.
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer - Pharmacy Times
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer Pharmacy Times
Published: May 22, 2026, 4:14 p.m.
New therapy bests chemo to improve survival in endometrial cancer - Rare Cancer News
New therapy bests chemo to improve survival in endometrial cancer Rare Cancer News
Published: May 20, 2026, 1:14 p.m.
The Four Types of Therapy for Second-Line Endometrial Cancer - CancerNetwork
The Four Types of Therapy for Second-Line Endometrial Cancer CancerNetwork
Published: May 16, 2026, 2:04 p.m.
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor - Femtech Insider
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor Femtech Insider
Published: May 15, 2026, 11:33 a.m.
UM research team identifies novel targeted therapy for endometrial cancer - University of Macau
UM research team identifies novel targeted therapy for endometrial cancer University of Macau
Published: May 13, 2026, 3:13 a.m.
Managing Progression After Immunotherapy in Endometrial Cancer - OncLive
Managing Progression After Immunotherapy in Endometrial Cancer OncLive
Published: May 5, 2026, 12:07 p.m.
Foregoing SLN breast surgery does not lead to radiation therapy increase - AuntMinnie
Foregoing SLN breast surgery does not lead to radiation therapy increase AuntMinnie
Published: May 1, 2026, 4:19 p.m.
Metabolomic Markers of Neurotransmitter-Related Metabolism in Women with Ovarian Endometriomas: The Role of the Kynurenine Pathway and Changes During Progestin Therapy - EMJ
Metabolomic Markers of Neurotransmitter-Related Metabolism in Women with Ovarian Endometriomas: The Role of the Kynurenine Pathway and Changes During Progestin Therapy EMJ
Published: April 30, 2026, 6:19 a.m.
Link copied to clipboard!